Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Japan’s Takeda to acquire US cancer drug manufacturer ARIAD for $5.2bn

pharmaceutical-technologyJanuary 11, 2017

Tag: Takeda , cancer drug

PharmaSources Customer Service